Skip to main content

Table 2 FIGO system for ovarian cancer staging

From: MR imaging of ovarian masses: classification and differential diagnosis

Stage I

Tumour confined to ovaries

I A

Tumour limited to 1 ovary, capsule intact, no tumour on surface, negative washings

I B

Tumour involves both ovaries otherwise like IA

I C

Tumour limited to 1 or both ovaries

I C1

Surgical spill

I C2

Capsule rupture before surgery or tumour on ovarian surface

I C3

Malignant cells in the ascites or peritoneal washings

Stage II

Tumour involves 1 or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer

II A

Extension and/or implant on uterus and/or Fallopian tubes

II B

Extension to other pelvic intraperitoneal tissues

Stage III

Tumour involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes

III A

Positive retroperitoneal lymph nodes and /or microscopic metastasis beyond the pelvis

III A1

Positive retroperitoneal lymph nodes only

III A2

Microscopic, extrapelvic (above the brim) peritoneal involvement ± positive retroperitoneal lymph nodes

III B

Macroscopic, extrapelvic, peritoneal metastasis ≤2 cm ± positive retroperitoneal lymph nodes. Includes extension to capsule of liver/spleen

III C

Macroscopic, extrapelvic, peritoneal metastasis >2 cm ± positive retroperitoneal lymph nodes. Includes extension to capsule of liver/spleen

Stage IV

Distant metastasis excluding peritoneal metastasis

IV A

Pleural effusion with positive cytology

IV B

Hepatic and/or splenic parenchymal metastasis, metastasis to extraabdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity)